Old and new strategies in induction therapy

A. Boehler (Zurich, Switzerland)

Source: School Course 2012 - Lung Transplantation
Number: 21

Slide presentationMultimedia files

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Boehler (Zurich, Switzerland). Old and new strategies in induction therapy. School Course 2012 - Lung Transplantation

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Old and new therapeutic options in BOS
Source: School Course 2012 - Lung Transplantation
Year: 2012


What’s new in induction therapy
Source: ERS Course 2016
Year: 2016




Systemic therapies: optimising the sequences of chemotherapies, targeted therapies and immunotherapies
Source: International Congress 2017 – PG1 Re-defining the role of chest physicians in lung cancer: new opportunities in diagnostics and therapy
Year: 2017


Optimizing the target therapy development
Source: ERS Research Seminar
Year: 2015


Combination therapy in the era of immunotherapy
Source: New biomarkers, molecules and therapeutic sequences for non small cell lung carcinoma in the era of precision medicine
Year: 2019


Old ideas to innovate tuberculosis control: preventive treatment to achieve elimination
Source: Eur Respir J 2013; 42: 785-801
Year: 2013



Current and future preventive and treatment strategies in CLAD
Source: International Congress 2015 – When chronic inflammation drives fibrosis: a lesson from lung transplantation
Year: 2015



How to stop LC-fILD progression: an overview of modern therapeutic strategies
Source: Virtual Congress 2021 – Lung cancer and fibrotic interstitial lung diseases: a challenging association for pulmonologists
Year: 2021


Alternative immunosuppressive strategies
Source: ERS Course 2016
Year: 2016

Potential of regulatory T-cell-based therapies in the management of severe COVID-19
Source: Eur Respir J, 56 (3) 2002182; 10.1183/13993003.02182-2020
Year: 2020



Clinical implications and opportunities for new drug therapies
Source: Annual Congress 2008 - Deadly networks: disease-causing protein and DNA modifications
Year: 2008


A new definition of multimodality treatment
Source: International Congress 2016 – Oligometastasis: postmodern multimodality concepts
Year: 2016